I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
. The purpose of this study is to investigate whether treatment with a drug called tesamorelin, which is a growth hormone releasing hormone analogue, will decrease liver fat and improve liver
proton magnetic resonance spectroscopy
cancer
liver disease
hepatitis b surface antigen
growth hormone
- 3 views
- 18 Feb, 2022